Cancer Rop Co. Ltd. (180400) — Capital Reinvestment Ratio
Latest as of December 2022:
2.01x
Cancer Rop Co. Ltd. (180400) has a Capital Reinvestment Ratio of 2.01x as of December 2022, meaning it reinvests 2% of its operating cash flow (₩865.55 Million) in capital expenditures (₩1.74 Billion). See how much free cash does Cancer Rop Co. Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.01x
Capex / Operating Cash Flow
Operating Cash Flow
₩865.55 Million
KRW
Capital Expenditures
₩1.74 Billion
KRW
Data as of
Dec 2022
Most recent filing
Cancer Rop Co. Ltd. Capital Reinvestment Ratio (2014–2022)
This chart tracks Cancer Rop Co. Ltd.'s Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Cancer Rop Co. Ltd. (2014–2022)
Year-by-year Capital Reinvestment Ratio for Cancer Rop Co. Ltd. from 2014 to 2022. For live market cap and broader valuation context, see Cancer Rop Co. Ltd. (180400) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.01x | ₩865.55 Million | ₩1.74 Billion | ▲ +397.1% |
| 2014 | 0.40x | ₩783.83 Million | ₩316.72 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow